Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.4000
-0.0500 (-11.11%)
Jul 13, 2026, 5:35 PM CET
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €199.78 million as of July 13, 2026. Its market cap has increased by 1,865.92% in one year.
Market Cap
199.78M
Enterprise Value
207.04M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.40
Market Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 199.78M, an increase of 174.54%. That is a compound annual growth rate of 5.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 199.78M | 196.14% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 881.33M |
| DBV Technologies | 843.95M |
| Genfit | 687.33M |
| Valneva SE | 413.24M |
| Transgene | 207.33M |
| Cellectis | 188.04M |
| Innate Pharma | 147.69M |
| Sensorion | 133.83M |